Dealing With the Left Atrial Appendage for Stroke Prevention: Devices and Decision-Making - 02/08/17
Résumé |
Left atrial appendage (LAA) device occlusion represents a major evolution in stroke prevention for atrial fibrillation (AF). Left atrial appendage device occlusion is now a proven strategy which provides long-term thromboembolic stroke prevention for patients with non-rheumatic AF. Evidence supports its benefit as an alternative to long-term anticoagulation while mitigating long-term bleeding risks and improving cardiovascular mortality. The therapy offers expanded options to physicians and patients negotiating stroke prevention (both primary and secondary prevention), but a good understanding of the risks and benefits is required for decision-making. This review aims to summarise the evolution of LAA device occlusion therapy, current knowledge in the field and a snapshot of current status of the therapy in clinical practice in Australia and around the world.
Le texte complet de cet article est disponible en PDF.Keywords : Stroke prevention, Left atrial appendage, Device occlusion, Atrial fibrillation, WATCHMAN, Amplatzer Cardiac plug
Plan
Vol 26 - N° 9
P. 918-925 - septembre 2017 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?